AzTrials
AzTrials

FrailtyFRAILMERITNCT05002439

RCT to Analyze the Efficacy of a Spanish Healthcare ministRy Based In InTervention to Reduce Frailty Status in Prefrail Older Adults

A study testing Multicomponent physical exercise program and a nutritional intervention in people with Frailty and Aged, run by Complejo Hospitalario Universitario de Albacete at 1 site in Spain.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Objectives: The main objective is to analyze the efficacy of an intervention based on the algorithm proposed by the Spanish Healtcare Ministry (see figure in annex 1) at Primary Care level to reduce Frailty status or Physical Function in community-dwelling older adults. Secondary objectives are: 1. Read more about this study

Who is it for?
Ages 70 to 100 years
Conditions the study is for
Frailty, Aged, Exercise
What is being tested?
Multicomponent physical exercise program and a nutritional intervention
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
273 participants
Where
1 siteSpain
Study dates
1 Jan 2020to 31 Mar 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 70 to 100 years
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Community-dwelling adults with age equal or greater than 70 years.
  • Barthel index > 85
  • Gait speed < 0.8 m/s OR frailty /prefrailty using the frailty phenotype
  • Ability to realize the physical exercise program
  • Capacity to understand the procedures and interventions of the trial
  • Capacity to understand and sign the informed consent

Who cannot join

  • Major contraindications for exercise: Severe aortic valve stenosis, myocardial infarction in the previous 6 weeks, Venous thromboembolic disease in the previous 6 weeks.
  • Inability to conduct the physical tests of the trial
  • Inability to understand the procedures of the trial
  • Active solid organ or hematologic neoplasm other than basocellular skin neoplasm, or life expectancy lower than one year.
  • Surgical intervention programmed that could interfere with the physical exercise program.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Pedro Abizanda Soler, MD,PhD contact

+34636557437

pabizanda@sescam.jccm.es

Almudena Avendaño Céspedes, RN, PhD contact

+34967597684

aavendanoc@sescam.jccm.es

Spain1 site, 1 recruiting
  • Complejo Hospitalario Universitario de Albacete

    Albacete, 02006

    Pedro Abizanda Soler, MD,PhD, +34967597684, pabizanda@sescam.jccm.es

    Almudena Avendaño Céspedes, RN, PhD, +34967597684, aavendanoc@sescam.jccm.es

    Recruiting

Other trials in Spain

About this study

Official title: Multicenter Randomized Clinical Trial to Analyze the Efficacy of a Spanish Healthcare ministRy Based In InTervention to Reduce Frailty Status in Prefrail Older Adults (FRAILMERIT)

Objectives: The main objective is to analyze the efficacy of an intervention based on the algorithm proposed by the Spanish Healtcare Ministry (see figure in annex 1) at Primary Care level to reduce Frailty status or Physical Function in community-dwelling older adults. Secondary objectives are: 1. To analyze if the intervention is cost-effective; 2. To analyze if the intervention reduces hospitalizations and emergency department visits, incident disability, falls, institutionalization, mortality, Primary Care visits and Drug use, and improves quality of life.

Methodology: Multicentric Randomized Clinical Trial in 273 Prefrail or Frail or with a gait speed lower that 0.8 m/s community-dwelling women and men with an age equal or greater to 70 years, attended in selected Primary Care centers of Spain (Albacete, Hellín, Barcelona, Madrid, La Carlota, and Tacoronte). Randomization will be made by clusters, being every cluster a different Primary Care center in order to avoid contamination. Randomization on a 1:1 relationship between groups. The main outcome variable will be Frailty status or Physical function change (main composite outcome) at 8-month follow-up measured with the Frailty Phenotype and the Short Physical Performance Battery (SPPB) respectively. All instrumentation will follow the guidelines of the Spanish Healthcare Ministry algorithm for frailty updated 2022. Intervention will consist on a groupal multicomponent physical exercise program, a nutritional intervention program and a training in Frailty to Primary Care centers. The intervention will be delivered by trained experts in groups of 6 participants, and will be based on the recommendations of the Spanish Healthcare Ministry document, updated in 2022.

Read the detailed description

Hypothesis An intervention based on the algorithm proposed by the Spanish Healtcare Ministry (see figure in annex 1) at Primary Care level will be effective in reducing Frailty status or Physical Function (composite outcome) in community-dwelling older adults.

Main Objective

To analyze the efficacy of an intervention based on the algorithm proposed by the Spanish Healtcare Ministry (see figure in annex 1) at Primary Care level to reduce Frailty status or Physical Function (composite outcome) in community-dwelling older adults.

Secondary objectives

  1. To analyze if the intervention is cost-effective 2. To analyze if the intervention reduces hospitalizations and emergency department visits 3. To analyze if the intervention reduces incident disability 4. To analyze if the intervention reduces falls 5. To analyze if the intervention reduces institutionalization 6. To analyze if the intervention improves quality of life 7. To analize if the intervention decreases mortality 8. To analyze if the intervention reduces Primary Care visits and Drug use
  2. Design Multicentric Randomized Clinical Trial
  3. Study subjects Prefrail or Frail or with a gait speed lower than 0.8 m/s community-dwelling women and men with an age equal or greater to 70 years, attended in selected Primary Care centers of Spain (Albacete, Hellín, Barcelona, Madrid, La Carlota, and Tacoronte). Sample size The sample size was calculated to find a difference between groups of 15% in the percentage of respondents (reduction in at least one frailty criteria); 25% in the intervention group (algorithm implementation) and 5% in the control group, alpha < 0.05 and power 80%. A 15% of loses will be assumed. Using the program GRANMO (https://www.imim.cat/ofertadeserveis/es_granmo.html), the number of participants per group is 82, for a total of 164 participants. However, due to COVID conditions, the sample size was increased up to 273 participants.
  4. Randomization Randomization will be made by clusters, being every cluster a different Primary Care center, in order to avoid contamination. Randomization will be computer-based with a 1:1 relationship between groups. Every Primary Care center will include at least 24 participants (two Primary Care Physicians at each one). Because exercise groups will be composed of 6 participants. For these reasons, 12 Primary Care centers will be needed, 6 with intervention and 6 control
  5. Instrumentation All instrumentation will follow the guidelines of the Spanish Healthcare Ministry algorithm for frailty, updated 2022. First, older adults attending the selected Primary Care centers (Albacete, Hellín, Barcelona, La Carlota, Tacoronte and Madrid) will receive a Barthel index assessment, a frailty phenotype assessment and a gait speed measurement in every Primary Care center. If patients present a Barthel index greater than 85 plus either a prefrailty or frailty say¡tutus or a walking speed lower than 0,8 m/s, they will be offered to entry the trial by the Primary Care Physician. In order to warrant the independence of recruitment, randomization of the Primary Care centers will be undertaken when a center arrives the 24 participants. If the center is considered "usual care", physicians will realize a baseline visit to participants, collecting all study variables, and will make healthy lifestyles recommendations. If the center is considered "intervention", physicians will realize a basal visit to participants collecting determined variables, and they will receive the intervention described below. Follow-up visits to analyze results will be conducted at 3, 5 and 8 months. Adverse events will be monitored and communicated on presentation. Monitoring will be conducted throughout the clinical trial.
  6. Data collection and analysis For this project we will use the tool "Research Electronic Data Capture" (REDCap) for Electronic Data Capture (EDC), designed for creating surveys and questions using branching logic and stop actions. Some of the question will be created as a data collection instrument, and other will be selected from the data collection instruments in REDCap shared library, a repository for data collection instruments and forms. REDCap is a web-based application developed by Vanderbilt University to capture data for clinical research. REDCap uses instruments such as surveys and forms as research capture tools and is designed to provide a secure environment so that research teams can collect and store highly sensitive information. They are workflow-based and focus on collecting data and exporting it to statistical programs and other data analysis software. More information can be viewed at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764586/. INVESTEN, participating in the Project will provide this tool for free. Data will be stored for up to 15 years by the investigators. All data will be anonimyzed and stored in a secure manner. Analysis will be maid on an intention-to-treat basis by the principal investigator that will be blinded to group assignment. Risk reduction will be presented for the principal variable. Differences in secondary objectives will be analyzed with risk reductions, difference of means or proportions when convenient.
  7. Economic models In order to collect information on the health and non-health resources consumption, specific questionnaires would be designed, for both, for patients as well as for caregivers. For the economic evaluation, we will perform two different analyses, a cost-effectiveness analysis (CEA) and a cost-utility analysis (CUA). The CEA will be carried out comparing both outcomes and monetary valuation of the resources used in the group of patients who receive the intervention with the control group (usual care). Thereby, the incremental cost-effectiveness ratio (ICER) reveals the cost per unit of benefit of switching from usual care to the intervention group. The health results measured by the ICER would be the following: Frailty status change, hospitalization, incident disability, and falls. Furthermore, CUA is a special type of cost-effectiveness analysis that uses the Quality-Adjusted Life-Year (QALY) as outcome. Both CEA and CUA would be conducted separately considering both the societal perspective (that is, all costs included) and the National Health System perspective (taking into consideration healthcare costs and costs related to the intervention). Additionally, several univariate sensitivity analysis as well as probabilistic sensitivity analysis will be carried out in order to test how sensitive the results obtained from the ICER and the ICUR are when varying both costs and health results.
  8. Ethics The Study has been approved by the Ethics Review Committee of Albacete (February meeting), and will be presented to the rest of local Ethics Committees. The information form for participants and informed consent is presented in the annexes. There have been two amendments to the first approved version, that were approved by the ethics committee, V3 in 2023 and the final V4 in 2025.
Conditions
Frailty, Aged, Exercise
Being tested
Multicomponent physical exercise program and a nutritional intervention
Keywords
Frailty, Aged, Multimodal training
Medical subject headings
Frailty, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Multicomponent physical exercise program and a nutritional interventionOther

    The exercise program will be delivered by trained experts in groups of 6 participants, and will be based on the recommendations presented in the Spanish Healthcare Ministry document. This program includes balance, flexibility, and strength and power exercises. The program will be realized twice a week, during 45 minutes time, for 16 weeks, twice a year. Nutritional intervention will be based on the results of MNA-SF. If the results of this instrument show normal nutrition status, general nutritional recommendations will de presented by a nutritionist twice a year before the physical exercise program. If MNA-SF shows nutritional risk or malnutrition, oral nutritional supplementation will be offered. Primary Care Physicians will have the opportunity of referring high risk participants to their Geriatrics Department Participants when appropriate, following Healthcare Ministry algorithm

Study groups in NCT05002439
Study groupRoleWhat they receive
Group multicomponent physical exercise program, nutritional intervention and Frailty trainingExperimentalGroup multicomponent physical exercise program, nutritional intervention program and Primary Care training in Frailty. The exercise program will be delivered by trained experts in groups of 6 participants, and will be based on the recommendations presented in the Spanish Healthcare Ministry document updated 2022. This program includes balance, flexibility, and strength and power exercises. The program will be realized twice a week, during 45 minutes time, for 12 weeks, twice, with a discontinuation period of 2 months. Nutritional recommendations will de presented by a nutritionist at the beginning of the intervention to the Primary Care physicians. Primary Care Physicians will have the opportunity of referring high risk participants to their Geriatrics Department Participants when appropriate, following Healthcare Ministry algorithm
Receives: Other: Multicomponent physical exercise program and a nutritional intervention
Control groupNo interventionControl group will receive usual care by their Primary Care Physicians. Healthy lifestyle recommendations including exercise and nutritional recommendations will be offered

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Frailty status or Physical Function change (composite outcome)

    Frailty will be determined with the Frailty Phenotype and Physical Function with the SPPB

    Measured: 8 months

Secondary outcomes (3)
  1. Hospitalization

    Number of hospitalizations during the follow-up for any cause.

    Measured: 1 year

  2. Emergency department visits

    Number of visits during the follow-up for any cause.

    Measured: 1 year

  3. Mortality

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Aug 2021
  2. Study start1 Jan 2020
  3. Primary completion31 Mar 2025 (estimated)
  4. Study completion31 Mar 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomization will be made by clusters, being every cluster a different Primary Care center in order to avoid contamination. Randomization on a 1:1 relationship between groups.
Masking
None (open label)
Enrolment
273 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05002439
Sponsor's protocol ID
FRAILMERIT
Acronym
FRAILMERIT
Status last verified
Mar 2025
First submitted
23 Jul 2021
Last updated
18 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Data will be shared on request. Study protocol, statistical analysis and clinical study report will be shared when data will be published in a Journal.

Publications

  • Kojima G, Iliffe S, Walters K. Frailty index as a predictor of mortality: a systematic review and meta-analysis. Age Ageing. 2018 Mar 1;47(2):193-200. doi: 10.1093/ageing/afx162.

    PubMed 29040347
  • Hoogendijk EO, Romero L, Sanchez-Jurado PM, Flores Ruano T, Vina J, Rodriguez-Manas L, Abizanda P. A New Functional Classification Based on Frailty and Disability Stratifies the Risk for Mortality Among Older Adults: The FRADEA Study. J Am Med Dir Assoc. 2019 Sep;20(9):1105-1110. doi: 10.1016/j.jamda.2019.01.129. Epub 2019 Mar 8.

    PubMed 30853426
  • Abizanda P, Romero L, Sanchez-Jurado PM, Martinez-Reig M, Gomez-Arnedo L, Alfonso SA. Frailty and mortality, disability and mobility loss in a Spanish cohort of older adults: the FRADEA study. Maturitas. 2013 Jan;74(1):54-60. doi: 10.1016/j.maturitas.2012.09.018. Epub 2012 Oct 26.

    PubMed 23107816
  • Kojima G. Frailty as a Predictor of Nursing Home Placement Among Community-Dwelling Older Adults: A Systematic Review and Meta-analysis. J Geriatr Phys Ther. 2018 Jan/Mar;41(1):42-48. doi: 10.1519/JPT.0000000000000097.

    PubMed 27341327
  • Kojima G. Frailty as a predictor of hospitalisation among community-dwelling older people: a systematic review and meta-analysis. J Epidemiol Community Health. 2016 Jul;70(7):722-9. doi: 10.1136/jech-2015-206978. Epub 2016 Mar 1.

    PubMed 26933121
  • Apostolo J, Cooke R, Bobrowicz-Campos E, Santana S, Marcucci M, Cano A, Vollenbroek-Hutten M, Germini F, D'Avanzo B, Gwyther H, Holland C. Effectiveness of interventions to prevent pre-frailty and frailty progression in older adults: a systematic review. JBI Database System Rev Implement Rep. 2018 Jan;16(1):140-232. doi: 10.11124/JBISRIR-2017-003382.

    PubMed 29324562
  • Tarazona-Santabalbina FJ, Gomez-Cabrera MC, Perez-Ros P, Martinez-Arnau FM, Cabo H, Tsaparas K, Salvador-Pascual A, Rodriguez-Manas L, Vina J. A Multicomponent Exercise Intervention that Reverses Frailty and Improves Cognition, Emotion, and Social Networking in the Community-Dwelling Frail Elderly: A Randomized Clinical Trial. J Am Med Dir Assoc. 2016 May 1;17(5):426-33. doi: 10.1016/j.jamda.2016.01.019. Epub 2016 Mar 3.

    PubMed 26947059
  • Abizanda Saro A, Garcia Molina R, Alcantud Corcoles R, Maestre Moreno M, Sanchez Uceda R, Moron Merchante I, Aragones Jimenez A, Gonzalez Cespedes MD, Montero Alia P, Simarro Rueda M, Torres Anton L, Martinez Garcia P, Soriano Fernandez H, Corcoles Garcia M, Reyes Abreu AM, Morcillo Gonzalez MN, Garcia Paez E, Rodriguez Sanchez B, Saez Blesa M, Cortes Zamora EB, Andres Pretel F, Avendano Cespedes A; FRAILMERIT Study Group; Abizanda P. Efficacy of a Multicomponent Intervention for Frailty or Physical Function in Prefrail or Frail Older Adults: FRAILMERIT Multicenter Clinical Trial. J Am Geriatr Soc. 2026 Mar;74(3):658-668. doi: 10.1111/jgs.70266. Epub 2025 Dec 28.

    PubMed 41456342

Questions about this trial

What is this clinical trial studying?

A study testing Multicomponent physical exercise program and a nutritional intervention in people with Frailty and Aged, run by Complejo Hospitalario Universitario de Albacete at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 18 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Pedro Abizanda Soler, MD,PhD (+34636557437, pabizanda@sescam.jccm.es), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Frailty status or Physical Function change (composite outcome) (time frame: 8 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05002439, which also lists 8 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in